Innovate Diagnostics for Value Creation | Hotgen successfully debuted at KONKER XI & PIT XXIII 2024 with its new in vitro diagnostic solution

From October 23 to 25, 2024, Beijing Hotgen Biotech Co., Ltd. successfully participated in the PANITIA KONFERENSI KERJA (KONKER) XI & PERTEMUAN ILMIAH TAHUNAN (PIT) XXIII 2024, held at the PADMA HOTEL in Semarang, Indonesia.

At this exhibition, Hotgen exhibited its market-recognized mono-test chemiluminescence and  up-converting phosphor immunoassay solutions, breakthrough technologies for small molecule immunoassays, and a variety of colloidal gold rapid test kit, attracting the attention and consultation of many participants. As a high-tech enterprise committed to "developing biotechnology and benefiting human health", Hotgen actively promotes advanced IVD (in vitro diagnostic) technology to help improve the capabilities of Indonesian testing laboratories.

During the exhibition, many industry experts and partners came to Hotgen's booth to discuss the development prospects of accurate and convenient diagnostic and physical examination solutions in Indonesia. Through this exhibition, Hotgen has further deepened its ties with the Indonesia market and demonstrated its cutting-edge technology and strength in the field of in vitro diagnostics.

Thank you for your attention and support, and we are looking forward to cooperating with you in the future to jointly promote the development of regional health career.